Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 13 Biotech Stocks with Huge Upside Potential. The company ...

The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce ...

Leaders of hundreds of public healthcare companies are in South Florida this week, talking up their innovations and financial ...

These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company ...

Clarajo Pleasants is amazed at the caliber of seniors who have passed through the youth group at Jamestown Presbyterian ...

Breathing—a natural and essential process—can be an incredibly labored process for people with cystic fibrosis. CF, a genetic ...

In epithelial cells, CFTR mediates Cl − secretion. Mutations in CFTR cause cystic fibrosis, whereas the activation of CFTR in the intestine causes secretory diarrhoea. Therefore the function and ...

Living with cystic fibrosis while facing homelessness has tested me in every way. However, through it all, I’ve found strength, purpose, and the unshakable belief that I must keep going — for myself ...

Participants depart for Bimini on June 18 to prepare, train, and connect as a team. When the horn sounds in the early hours ...

Boehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium announced a global collaboration to develop a first-in-class, long-term therapy for patients with cystic fibrosis (CF).

Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic fibrosis (CF), which offer a different mechanism to those sold by market ...